Furthermore, our RNA-seq studies show that loss of Irf1 causes basal alterations in colonic immune and epithelial transcriptional programs (Fig. 2), which may promote a “tumor-permissive” microenvironment. This evidence concerns the gene IRF1 and neoplasm.